Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 23, 2023 04:51 ET | Source: Zion Market Research

Global CAR T-Cell Therapy Market Size on a Meteoric Rise: Envisioning $2406.39 Million by 2030 with a Striking CAGR of 26.20%

New York, NY, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “CAR T-Cell Therapy Market By Drug Type (Axicabtagene Ciloleucel, Brexucabtagene...
March 30, 2023 02:00 ET | Source: Mendus AB

Mendus presenterar en uppdatering vid den 8:e årliga Innate Killer-konferensen avseende användningen av sin DCOne-plattform för att producera terapier baserade på högkvalitativa NK-celler

DCONE-DRIVEN EXPANSION AV MINNES-NK-CELLER LÄGGER GRUNDEN FÖR NYA EGENUTVECKLADE PIPELINEPROGRAM Mendus AB (“Mendus” publ; IMMU.ST), ett bioläkemedelsföretag fokuserat på immunterapier som tar sig...
March 30, 2023 02:00 ET | Source: Mendus AB

Mendus presents an update on the use of its DCOne platform to source high-quality NK cell therapies at the 8th Annual Innate Killer Summit

DCONE-DRIVEN EXPANSION OF MEMORY NK CELLS BUILDS THE BASIS FOR NOVEL PROPRIETARY PIPELINE PROGRAM Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies...
November 03, 2022 09:10 ET | Source: Mendus AB

Mendus AB: Mendus presenterar flera abstracts på ASH 2022, inklusive en muntlig presentation av uppdaterade AML-överlevnadsresultat från fas 2-studien ADVANCE II

Mendus AB (“Mendus” publ; IMMU.ST, eller “Bolaget”), ett bioläkemedelsföretag fokuserat på immunterapier som adresserar tumöråterfall, kan idag meddela att uppdaterade resultat från bolagets pågående...
November 03, 2022 09:10 ET | Source: Mendus AB

Mendus AB: Mendus to present multiple abstracts at ASH 2022 including an oral presentation of updated AML survival results from the Phase 2 ADVANCE II trial

Mendus AB (“Mendus” publ; IMMU.ST, or “the Company”), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that updated results from the Company’s...
June 16, 2022 10:00 ET | Source: NasoNeb, Inc.

NasoNeb is now a Division of Monaghan Medical Corporation

PLATTSBURGH, N.Y., June 16, 2022 (GLOBE NEWSWIRE) -- NasoNeb®, Inc. is proud to announce their integration with Monaghan Medical Corporation (“Monaghan Medical”) in Plattsburgh, New York. Monaghan...
October 28, 2021 10:09 ET | Source: NasoNeb, Inc.

NasoNeb Welcomes Leading Otolaryngologists to Medical Advisory Board

PLATTSBURGH, N.Y., Oct. 28, 2021 (GLOBE NEWSWIRE) -- NasoNeb, Inc. (the “Company” or “NasoNeb”), a developer of innovative intranasal drug delivery and nasal care solutions, is proud to welcome Dr....
May 19, 2016 17:36 ET | Source: California Life Sciences Association

In Case You Missed It: Lupus Patient Underscores Need for Medical Innovations

SACRAMENTO, Calif., May 19, 2016 (GLOBE NEWSWIRE) -- The Orange County Register published an opinion piece today by Bridget Hood, a lupus survivor and Lupus L.A. board member and support group...
March 21, 2011 11:13 ET | Source: Megadyne Medical Products, Inc.

MEGADYNE Introduces Modified ACE Blade(R) With Enhanced PTFE Insulation

PHILADELPHIA, PA--(Marketwire - March 21, 2011) - AORN Annual Congress (Booth #925) -- Megadyne today announced the addition of Modified ACE Blades to the Megadyne Advanced Cutting System...
April 14, 2010 10:00 ET | Source: Technology Innovation in Plastic Surgery

First-Ever Plastic Surgery Innovation Forum Will Gather Multi-Disciplinary Leadership Group to Stimulate Collaboration and Development

PALO ALTO, CA--(Marketwire - April 14, 2010) - Successful clinical innovation. Collaborative partnerships. New technology solutions. These key issues will be the focus of the first annual...